Search hospitals > Quebec > MONTREAL
The Montreal Children's Hospital of the MUHC
Claim this profileMONTREAL, Quebec H3H 1P3
Global Leader in Brain Tumor
Global Leader in Acute Lymphoblastic Leukemia
Conducts research for Leukemia
Conducts research for Solid Tumors
Conducts research for Cancer
254 reported clinical trials
12 medical researchers
Summary
The Montreal Children's Hospital of the MUHC is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Brain Tumor, Acute Lymphoblastic Leukemia, Leukemia, Solid Tumors, Cancer and other specialties. The Montreal Children's Hospital of the MUHC is involved with conducting 254 clinical trials across 468 conditions. There are 12 research doctors associated with this hospital, such as Sharon B. Abish, Genevieve Legault, MD, Pia Wintermark, MD, and Catherine Vezina, MD.Area of expertise
1Brain Tumor
Global LeaderStage IV
Stage II
Stage I
2Acute Lymphoblastic Leukemia
Global LeaderStage II
BCR-ABL1 fusion positive
ABL-class fusion positive
Top PIs
Sharon B. AbishThe Montreal Children's Hospital of the MUHC6 years of reported clinical research
Studies Cancer
Studies Burkitt Lymphoma
29 reported clinical trials
74 drugs studied
Genevieve Legault, MDMontreal Children's Hospital1 year of reported clinical research
Studies Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
8 reported clinical trials
12 drugs studied
Pia Wintermark, MDMontreal Children's Hospital6 years of reported clinical research
Studies Birth Asphyxia
Studies Birth asphyxia
2 reported clinical trials
2 drugs studied
Catherine Vezina, MDThe Montreal Children's Hospital (MUHC-McGill)9 years of reported clinical research
Studies Acute Lymphoblastic Leukemia
Studies Lymphoblastic Leukemia
2 reported clinical trials
3 drugs studied
Clinical Trials running at The Montreal Children's Hospital of the MUHC
Brain Tumor
Testicular cancer
Glioblastoma
Diffuse Intrinsic Pontine Glioma
Brain Cancer
Neuroblastoma
Ovarian Carcinoma
Ovarian Tumors
Testicular Carcinoma
Ovarian Choriocarcinoma
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Lower Radiotherapy Dose
for Brain Tumors
This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.
Recruiting1 award Phase 210 criteria
Health Information Collection
for Childhood Cancer
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Recruiting1 award N/A10 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at The Montreal Children's Hospital of the MUHC?
The Montreal Children's Hospital of the MUHC is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Brain Tumor, Acute Lymphoblastic Leukemia, Leukemia, Solid Tumors, Cancer and other specialties. The Montreal Children's Hospital of the MUHC is involved with conducting 254 clinical trials across 468 conditions. There are 12 research doctors associated with this hospital, such as Sharon B. Abish, Genevieve Legault, MD, Pia Wintermark, MD, and Catherine Vezina, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.